Search Results 1041-1050 of 18838 for Insulin
... insulin regulation of lipolysis resulting from treatment with the PPARγ agonist pioglitazone, with or without weight loss, can be linked to specific changes ...
... insulin-like growth factor-1 (IGF-I) production, thus favoring development of metabolic syndrome in men treated with toremifene, a new estrogen antagonist ...
Learn how heart experts evaluate and treat people with inherited lipid disorders, which put them at high risk of heart attacks.
This is a pilot study to evaluate whether targeting inflammation will help reduce markers of insulin resistance inflammation, bone resorption and physical ...
Discovery Science. A Line in the Sand – Mayo Clinic's role in insulin research. Mayo Clinic Staff. June 17, 2015. Research. Clinician-investigator: Translating ...
Insulin aspart, recombinant (intravenous route, subcutaneous route). Merilog. Also known as. Insulin aspart-szjj (subcutaneous route) · Meropenem (intravenous ...
Insulin glargine, recombinant (subcutaneous route). Semglee Pen. Also known as. Insulin glargine-yfgn, recombinant (subcutaneous route). Semprex-D. Also known ...
A Study to Evaluate Molecular Mechanisms of Exercise Benefits in Insulin Resistant People Rochester, MN. The aim of the study is to investigate the effects ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.